Erlotinib Hydrochloride CAS 183319-69-9 Bohloeki >99.0% (HPLC)
Moetsi ea ka sehloohong le mofani oa thepa ea Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-one CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Lebitso la Lik'hemik'hale | Erlotinib Hydrochloride |
Litlhaloso tse tšoanang | Erlotinib HCl;Tarceva;CP-358774 Hydrochloride;6,7-Bis(2-methoxyethoxy) -4-(3-ethynylanilino)quinazoline Hydrochloride;N-(3-Ethynylphe nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl |
Nomoro ea CAS | 183319-69-9 |
Nomoro ea KAtse | RF-PI2242 |
Boemo ba Setoko | Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane |
Foromo ea limolek'hule | C22H24ClN3O4 |
Boima ba Molek'hule | 429.90 |
Brand | Ruifu Chemical |
Ntho | Litlhaloso |
Ponahalo | Phofo ea Crystalline e tšoeu ho isa ho e tšoeu |
Boitsebiso | A: IR: E Ikamahanya le Reference Spectrum B: HPLC: E Ikamahanya le Reference RT |
Solubility | Ha Hanyane Hanyenyane ka Metsing, Ha Hanyenyane Hanyenyane ka Methanol 'me ha e khonehe ho Acetonitrile, Acetone, Ethyl Acetate le Hexane. |
Melting Point | 223.0~229.0℃ |
Tahlehelo ka ho Omisa | <0.50% |
Masalla a ho Ignition | <0.20% |
Litšepe tse boima | <20ppm |
Tšilafalo e le Mong | <0.50% |
Litšila ka Kakaretso | <1.00% |
Metsoako e setseng | |
Pyridine | <4000ppm |
Chloroform | <4000ppm |
DMF | <3000ppm |
Mokhoa oa Bohloeki / Analysis | >99.0% |
Mokhoa oa ho hlahloba / oa ho hlahloba | 98.5%~101.0% (E baloa ka Motheo oa Anhydrous) |
Tekanyetso ea Teko | Maemo a Khoebo |
Tšebeliso | API |
Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.
Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo
Erlotinib Hydrochloride (CAS: 183319-69-9) ke molek'hule e nyane ea epidermal growth factor receptor tyrosine kinase reversible inhibitor, e sebelisoa haholo kalafong ea mofets'e oa mofets'e o seng o monyane oa sele ea matšoafo le kalafo ea mela ea bobeli kapa e meraro. kankere ea pancreatic.Erlotinib Hydrochloride e amohetsoe ka Pulungoana, 2004, bakeng sa kalafo ea mofetše oa matšoafo o tsoetseng pele kapa oa metastatic o seng o nyane.Ke ea sehlopha se tšoanang le Gefitinib, quinazoline e 'ngoe e amohelehang bakeng sa phekolo ea kankere ea matšoafo e tsoetseng pele, empa e na le thepa e ntlafetseng ea pharmacokinetic.Molek'hule e thehiloe ke Pfizer mme nts'etsopele e qalile ka ts'ebelisano le OSI, e neng e nka litokelo tse feletseng tsa lithethefatsi ha Pfizer e kopana le Warner Lambert.Kamora moo, Genentech/Roche e ile ea kena tumellanong ea laesense le OSI ho nts'etsapele le ho bapatsa sethethefatsi sena US le Lefatšeng ka Bophara.Khetho ea epidermal growth factor receptor (EGFR) -tyrosine kinase inhibitor.Antineoplastic.Erlotinib Hydrochloride ke HER1/EGFR inhibitor e nang le IC50 ea 2 nM.Erlotinib HCl e fumaneha e le matlapa a 25-, 100-, le 150-mg bakeng sa tsamaiso ea molomo.